Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan ; volume:6 ; number:2 ; day:8 ; month:11 ; year:2017 ; pages:197-211 ; date:12.2017
Neurology and Therapy ; 6, Heft 2 (8.11.2017), 197-211, 12.2017
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Saida, Takahiko
- Beteiligte Personen und Organisationen
-
Yokoyama, Kazumasa
Sato, Ryusuke
Makioka, Haruki
Iizuka, Yukihiko
Hase, Masakazu
Ling, Yan
Torii, Shinichi
SpringerLink (Online service)
- DOI
-
10.1007/s40120-017-0084-6
- URN
-
urn:nbn:de:1111-201801257054
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.20020000, 01:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saida, Takahiko
- Yokoyama, Kazumasa
- Sato, Ryusuke
- Makioka, Haruki
- Iizuka, Yukihiko
- Hase, Masakazu
- Ling, Yan
- Torii, Shinichi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data